Morales, Leah Mae R.
HRN: 22-95-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2023
DOXYCYCLINE 100MG (CAP)
05/05/2023
05/10/2023
PO
100mg
BID
Pelvic Inflammatory Disease
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes